Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,771 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies.
Haselmayer P, Camps M, Muzerelle M, El Bawab S, Waltzinger C, Bruns L, Abla N, Polokoff MA, Jond-Necand C, Gaudet M, Benoit A, Bertschy Meier D, Martin C, Gretener D, Lombardi MS, Grenningloh R, Ladel C, Petersen JS, Gaillard P, Ji H. Haselmayer P, et al. Among authors: martin c. Front Immunol. 2014 May 22;5:233. doi: 10.3389/fimmu.2014.00233. eCollection 2014. Front Immunol. 2014. PMID: 24904582 Free PMC article.
Consideration of disease penetrance in the selection of secondary findings gene-disease pairs: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Gordon AS, Lee K, Abul-Husn NS, Amendola LM, Brothers K, Chung WK, Gollob MH, Harrison SM, Hershberger RE, Richards CS, Stewart DR, Martin CL, Miller DT; ACMG Secondary Findings Working Group. Electronic address: documents@acmg.net. Gordon AS, et al. Among authors: martin cl. Genet Med. 2024 May 30:101142. doi: 10.1016/j.gim.2024.101142. Online ahead of print. Genet Med. 2024. PMID: 38819344 No abstract available.
Smart goggles augmented reality CT-US fusion compared to conventional fusion navigation for percutaneous needle insertion.
Borde T, Saccenti L, Li M, Varble NA, Hazen LA, Kassin MT, Ukeh IN, Horton KM, Delgado JF, Martin C 3rd, Xu S, Pritchard WF, Karanian JW, Wood BJ. Borde T, et al. Among authors: martin c 3rd. Int J Comput Assist Radiol Surg. 2024 May 30. doi: 10.1007/s11548-024-03148-5. Online ahead of print. Int J Comput Assist Radiol Surg. 2024. PMID: 38814530
Implementation of a virtual community of practice to promote the empowerment of middle-aged people with multimorbidity: study protocol of a randomised controlled trial.
Campillejo A, Gefaell-Larrondo I, Ramos-García V, Koatz D, Santos-Álvarez A, Barrio-Cortes J, Gómez-Rueda S, Calderón-Larrañaga A, Cifuentes P, Company-Sancho C, Domínguez-Coello S, García-García FJ, Garrido-Elustondo S, González de León B, Ramón-Vazquez J, Martín C, Suárez-Fernández C, Parra-Caballero P, Vicente-Rabaneda EF, Quiroga-Colina P, Ramírez-Puerta AB, Ruíz-López M, Tello-Bernabé ME, Sanchez-Gamborino E, Ugalde-Abiega B, Vall-Roqué H, Duarte-Díaz A, Abt-Sacks A, Hernández-Yumar A, Torres-Castaño A, Álvarez-Pérez Y, Muth C, van den Akker M, Montori VM, Orrego C, Perestelo-Pérez L, González-González AI. Campillejo A, et al. Among authors: martin c. BMJ Open. 2024 May 24;14(5):e084937. doi: 10.1136/bmjopen-2024-084937. BMJ Open. 2024. PMID: 38803252 Free PMC article.
Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates.
Peralta Alvarez MP, Jones H, Redondo Azema H, Davis C, White AD, Sarfas C, Dennis M, Li S, Wright D, Puentes E, Kimuda S, Belij-Rammerstorfer S, Aguilo N, Martin C, Sharpe S, McShane H, Tanner R. Peralta Alvarez MP, et al. Among authors: martin c. Front Immunol. 2024 May 10;15:1387454. doi: 10.3389/fimmu.2024.1387454. eCollection 2024. Front Immunol. 2024. PMID: 38799468 Free PMC article.
10,771 results
You have reached the last available page of results. Please see the User Guide for more information.